SoftOx Solutions AS (OSL: SOFTX)

Market Cap	26.54M
Revenue (ttm)	1.52M
Net Income (ttm)	-72.73M
Shares Out	1.95B
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,782,370
Average Volume	4,076,443
Open	0.0134
Previous Close	0.0134
Day's Range	0.0122 - 0.0138
52-Week Range	0.0100 - 2.7800
Beta	-2.28
RSI	45.81
Earnings Date	Mar 5, 2025

About SoftOx Solutions AS

SoftOx Solutions AS, together with its subsidiaries, operates as a medtech and clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway. Its products include SafeDes+, a hand disinfectant for irritated, compromised, and eczematous skin; and EffectDesH, a surface disinfectant, which has a killing/inactivation effect on bacteria, viruses, yeast, fungi, mycobacterium, and spores. The company also provides human wound and infection treatment products comprising SoftOx Wound Irrigat...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2012
• Employees: 7
• Stock Exchange: Oslo Børs
• Ticker Symbol: SOFTX

Financial Performance

In 2023, SoftOx Solutions AS's revenue was 6.98 million, a decrease of -1.88% compared to the previous year's 7.11 million. Losses were -39.45 million, -44.55% less than in 2022.